Year None202520242023202220212020201920182017201620152014201320122011201020092008 Jan 13, 2025 Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio Read More PDF Version Jan 08, 2025 FDA Accepts Agios’ Supplemental New Drug Application for PYRUKYND® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia Read More PDF Version Jan 03, 2025 Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025 Read More PDF Version
Jan 13, 2025 Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio Read More PDF Version
Jan 08, 2025 FDA Accepts Agios’ Supplemental New Drug Application for PYRUKYND® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia Read More PDF Version
Jan 03, 2025 Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025 Read More PDF Version
